Pharmaceutical Solutions Provider Skila - Launches iLaunch - The Next Generation Management Support Solutions Designed to Maximize Pharmaceutical Product Lifecycles
Morris Plains, NJ, July 19, 2005 - Skila, a Sela2
Company, announces the introduction of iLaunch,
the next generation of its unique solutions targeted at managing the complexities
of commercializing new products and successfully launching them. In today's
fast paced pharmaceutical business, new products define a company's
future. Because of the heavy initial investment required to develop new
pharmaceuticals, most companies are clearly seeking to maximize the lifecycle
potential of every new product that hits the market. However, due to the
complexities involved in pharmaceutical development, new product launches
are typically plagued by issues that challenge their success. Most of
the critical challenges revolve around the following key areas:
Synchronizing the goals and efforts of global cross-functional teams
An effective management system for global product teams that applies
best practice team communication in brand knowledge, advocacy, and competitive
intelligence
A performance measurement system that continuously measures progress
and enables proactive adjustments to changing conditions
Skila's vast experience in supporting global product launches for
its partners led to the development of iLaunch,
the next generation product management solution. iLaunch
is a Product Management Solution that provides global product teams a
communication and knowledge environment necessary to successfully manage
products from late development to launch and beyond. iLaunch
enables global product teams to increase effectiveness by integrating
knowledge into planning, execution, and performance measurement. iLaunch
is easily integrated into the global product teams workflow and focuses
on improving their management and communication both cross-functionally
and between countries.
iLaunch capabilities enhance the global product teams' ability to communicate product
knowledge, manage advocacy relationships, and proactively manage competitive
intelligence. Evolving a global product team to improve effectiveness
is a significant challenge. iLaunch
helps teams minimize these barriers through a unique technology, proven
methodology, and supporting services. iLaunch
a turnkey solution which can be established and configured within days.
The solution utilizes Skila's proprietary Intelligration® platform
which integrates critical business knowledge from multiple data sources
and aligns it around the organization's goals and objectives. "In
an environment where a new product represents an investment of over $700
million, Pharmaceutical companies increasingly want to ensure that their
teams are working synergistically." commented Todd Harrell, Vice
President of Marketing at Skila. "The unique relationships we have
with our partners have given us a strong foundation upon which to develop
iLaunch."
About Skila
Skila is a global technology and services company specializing in knowledge and effectiveness solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams. These solutions include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.
Having developed strong relationships with a broad number of global Pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and over 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the long-term growth and adoption of our methodology, technology and continuous services as the business platform of choice for many of our clients.
